A thiourea‐bridged 99mTc(CO)3‐dipicolylamine‐2‐nitroimidazole complex for targeting tumor hypoxia: Utilizing metabolizable thiourea‐bridge to improve pharmacokinetics
Open Access
- 10 September 2024
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 85 (6) , e22258
Abstract
The 2‐nitroimidazole based 99mTc‐radiopharmaceuticals are widely explored for imaging tumor hypoxia. Radiopharmaceuticals for targeting hypoxia are often lipophilic and therefore, show significant uptake in liver and other vital organs. In this context, lipophilic radiopharmaceuticals with design features enabling faster clearance from liver may be more desirable. A dipicolylamine‐NCS bifunctional chelator that could generate a thiourea‐bridge up on conjugation to primary amine bearing molecule was used to synthesize a 2‐nitroimidazole‐dipicolyl amine ligand for radiolabeling with 99mTc(CO)3 core. Corresponding Re(CO)3‐analogue was prepared to establish the structure of 2‐nitroimidazole‐99mTc(CO)3 complex prepared in trace level. The 2‐nitroimidazole‐99mTc(CO)3 complex showed a hypoxic to normoxic ratio of ~2.5 in CHO cells at 3 h. In vivo, the complex showed accumulation and retention in tumor with high tumor to blood and tumor to muscle ratio. The study demonstrated the utility of metabolizable thiourea‐bridge in 2‐nitroimidazole‐99mTc(CO)3 complex in inducing faster clearance of the radiotracer from liver. The dipicolylamine‐NCS bifunctional chelator reported herein can also be used for radiolabeling other class of target specific molecules with 99mTc(CO)3 core.Keywords
This publication has 47 references indexed in Scilit:
- Molecular imaging of tumor hypoxia: Evolution of nitroimidazole radiopharmaceuticals and insights for future developmentBioorganic Chemistry, 2023
- Technetium(I) carbonyl complexes for nuclear medicine: Coordination-chemical aspectCoordination Chemistry Reviews, 2022
- Preparation and preliminary evaluation of a tris-metronidazole-99mTc(CO)3 complex for targeting tumor hypoxiaJournal of Radioanalytical and Nuclear Chemistry, 2018
- Modulation of in vivo distribution through chelator: Synthesis and evaluation of a 2-nitroimidazole–dipicolylamine–99mTc(CO)3 complex for detecting tumor hypoxiaBioorganic & Medicinal Chemistry Letters, 2016
- Positron emission tomography radiotracers for imaging hypoxiaJournal of Labelled Compounds and Radiopharmaceuticals, 2013
- On Quantitative Relationships Between Drug-Like Compound Lipophilicity and Plasma Free Fraction in Monkey and HumanJournal of Pharmaceutical Sciences, 2012
- Synthesis and biodistribution of a novel 99mTc-DMSA-metronidazole ester as a potential tumor hypoxia imaging agentJournal of Radioanalytical and Nuclear Chemistry, 2010
- On the isolation and evaluation of a novel unsubstituted 5-nitroimidazole derivative as an agent to target tumor hypoxiaBioorganic & Medicinal Chemistry Letters, 2008
- Biodistribution of Tc-99m methoxy-isobutyl-isonitrile (MIBI) in humansEuropean Journal of Nuclear Medicine and Molecular Imaging, 1989
- S-oxygenation of N-substituted thioureas catalyzed by the pig liver microsomal FAD-containing monooxygenaseArchives of Biochemistry and Biophysics, 1979